ArticleCancer cell2016

Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy.

Michael P Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.